HER-2 PROTEIN OVEREXPRESSION
Clinical trials for HER-2 PROTEIN OVEREXPRESSION explained in plain language.
Never miss a new study
Get alerted when new HER-2 PROTEIN OVEREXPRESSION trials appear
Sign up with your email to follow new studies for HER-2 PROTEIN OVEREXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists reprogram immune cells to hunt deadly sarcomas
Disease control Recruiting nowThis early-stage study is testing the safety of a two-part treatment for advanced sarcomas that have stopped responding to standard therapies. Doctors take a patient's own immune cells, genetically modify them to recognize and attack cancer cells, and then infuse them back. These…
Matched conditions: HER-2 PROTEIN OVEREXPRESSION
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New drug trial targets multiple advanced cancers with common genetic marker
Disease control Recruiting nowThis study is testing an experimental drug called zanidatamab for people with advanced cancers that have a specific genetic marker called HER2. The trial will enroll about 200 adults whose cancers have progressed after at least one prior treatment. Researchers want to see if the …
Matched conditions: HER-2 PROTEIN OVEREXPRESSION
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC